A new trading day began on Monday, with Pacira BioSciences Inc (NASDAQ: PCRX) stock price up 3.79% from the previous day of trading, before settling in for the closing price of $21.38. PCRX’s price has ranged from $16.00 to $27.64 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -51.99%. Meanwhile, its annual earnings per share averaged -10.24%. With a float of $43.70 million, this company’s outstanding shares have now reached $44.90 million.
Pacira BioSciences Inc (PCRX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Pacira BioSciences Inc is 2.74%, while institutional ownership is 115.07%. The most recent insider transaction that took place on Sep 04 ’25, was worth 64,005. In this transaction Director of this company sold 2,354 shares at a rate of $27.19, taking the stock ownership to the 9,039 shares. Before that another transaction happened on Sep 04 ’25, when Company’s Director proposed sale 2,354 for $27.19, making the entire transaction worth $64,005.
Pacira BioSciences Inc (PCRX) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of 0.79 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.86 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -10.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.44% during the next five years compared to -51.99% drop over the previous five years of trading.
Pacira BioSciences Inc (NASDAQ: PCRX) Trading Performance Indicators
Here are Pacira BioSciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.41. Likewise, its price to free cash flow for the trailing twelve months is 8.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.79, a number that is poised to hit 0.65 in the next quarter and is forecasted to reach 3.25 in one year’s time.
Technical Analysis of Pacira BioSciences Inc (PCRX)
Looking closely at Pacira BioSciences Inc (NASDAQ: PCRX), its last 5-days average volume was 0.66 million, which is a drop from its year-to-date volume of 0.75 million. As of the previous 9 days, the stock’s Stochastic %D was 56.12%.
During the past 100 days, Pacira BioSciences Inc’s (PCRX) raw stochastic average was set at 30.13%, which indicates a significant decrease from 64.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.93 in the past 14 days, which was higher than the 0.87 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $24.59, while its 200-day Moving Average is $24.58. However, in the short run, Pacira BioSciences Inc’s stock first resistance to watch stands at $22.83. Second resistance stands at $23.47. The third major resistance level sits at $24.20. If the price goes on to break the first support level at $21.46, it is likely to go to the next support level at $20.73. Now, if the price goes above the second support level, the third support stands at $20.09.
Pacira BioSciences Inc (NASDAQ: PCRX) Key Stats
With a market capitalization of 997.06 million, the company has a total of 44,933K Shares Outstanding. Currently, annual sales are 700,970 K while annual income is -99,560 K. The company’s previous quarter sales were 181,100 K while its latest quarter income was -4,850 K.
